C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP

Abstract Subjects carrying the C2238 variant of the atrial natriuretic peptide (ANP) gene have a higher occurrence of stroke and acute coronary syndrome, suggesting an increased predisposition to acute thrombotic events in these subjects. We evaluated for the first time the direct effects of mutant...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Roberto Carnevale, Pasquale Pignatelli, Giacomo Frati, Cristina Nocella, Rosita Stanzione, Daniele Pastori, Simona Marchitti, Valentina Valenti, Maria Santulli, Emanuele Barbato, Teresa Strisciuglio, Leonardo Schirone, Carmine Vecchione, Francesco Violi, Massimo Volpe, Speranza Rubattu, Sebastiano Sciarretta
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5096f14f92b54f8a9f71e3827294a48d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5096f14f92b54f8a9f71e3827294a48d
record_format dspace
spelling oai:doaj.org-article:5096f14f92b54f8a9f71e3827294a48d2021-12-02T12:31:50ZC2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP10.1038/s41598-017-03679-92045-2322https://doaj.org/article/5096f14f92b54f8a9f71e3827294a48d2017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03679-9https://doaj.org/toc/2045-2322Abstract Subjects carrying the C2238 variant of the atrial natriuretic peptide (ANP) gene have a higher occurrence of stroke and acute coronary syndrome, suggesting an increased predisposition to acute thrombotic events in these subjects. We evaluated for the first time the direct effects of mutant ANP (C2238/αANP) on platelet activation in vitro and in human subjects. In vitro, platelets were incubated with no peptide, with T2238/αANP (WT) or with C2238/αANP at different concentrations. C2238/αANP (10−10 M) induced higher collagen-induced platelet aggregation with respect to both control without ANP and T2238/αANP. This effect was even stronger at a higher concentration (10−6 M). Mechanistically, C2238/αANP significantly lowered platelet cAMP levels, increased ROS production and activated Nox2, with respect to both control and T2238/αANP. Forskolin, a cAMP activator, and sNOX2-tat, a Nox2 inhibitor, significantly reduced the pro-aggregant effects of C2238/αANP. In vivo, we found that platelet aggregation resulted to be higher in patients with atrial fibrillation carrying the C2238 ANP gene variant with respect to non-carriers. In conclusions, C2238/αANP promotes platelet aggregation through the activation of Nox2 and the reduction of cAMP.Roberto CarnevalePasquale PignatelliGiacomo FratiCristina NocellaRosita StanzioneDaniele PastoriSimona MarchittiValentina ValentiMaria SantulliEmanuele BarbatoTeresa StrisciuglioLeonardo SchironeCarmine VecchioneFrancesco VioliMassimo VolpeSperanza RubattuSebastiano SciarrettaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Roberto Carnevale
Pasquale Pignatelli
Giacomo Frati
Cristina Nocella
Rosita Stanzione
Daniele Pastori
Simona Marchitti
Valentina Valenti
Maria Santulli
Emanuele Barbato
Teresa Strisciuglio
Leonardo Schirone
Carmine Vecchione
Francesco Violi
Massimo Volpe
Speranza Rubattu
Sebastiano Sciarretta
C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP
description Abstract Subjects carrying the C2238 variant of the atrial natriuretic peptide (ANP) gene have a higher occurrence of stroke and acute coronary syndrome, suggesting an increased predisposition to acute thrombotic events in these subjects. We evaluated for the first time the direct effects of mutant ANP (C2238/αANP) on platelet activation in vitro and in human subjects. In vitro, platelets were incubated with no peptide, with T2238/αANP (WT) or with C2238/αANP at different concentrations. C2238/αANP (10−10 M) induced higher collagen-induced platelet aggregation with respect to both control without ANP and T2238/αANP. This effect was even stronger at a higher concentration (10−6 M). Mechanistically, C2238/αANP significantly lowered platelet cAMP levels, increased ROS production and activated Nox2, with respect to both control and T2238/αANP. Forskolin, a cAMP activator, and sNOX2-tat, a Nox2 inhibitor, significantly reduced the pro-aggregant effects of C2238/αANP. In vivo, we found that platelet aggregation resulted to be higher in patients with atrial fibrillation carrying the C2238 ANP gene variant with respect to non-carriers. In conclusions, C2238/αANP promotes platelet aggregation through the activation of Nox2 and the reduction of cAMP.
format article
author Roberto Carnevale
Pasquale Pignatelli
Giacomo Frati
Cristina Nocella
Rosita Stanzione
Daniele Pastori
Simona Marchitti
Valentina Valenti
Maria Santulli
Emanuele Barbato
Teresa Strisciuglio
Leonardo Schirone
Carmine Vecchione
Francesco Violi
Massimo Volpe
Speranza Rubattu
Sebastiano Sciarretta
author_facet Roberto Carnevale
Pasquale Pignatelli
Giacomo Frati
Cristina Nocella
Rosita Stanzione
Daniele Pastori
Simona Marchitti
Valentina Valenti
Maria Santulli
Emanuele Barbato
Teresa Strisciuglio
Leonardo Schirone
Carmine Vecchione
Francesco Violi
Massimo Volpe
Speranza Rubattu
Sebastiano Sciarretta
author_sort Roberto Carnevale
title C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP
title_short C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP
title_full C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP
title_fullStr C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP
title_full_unstemmed C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP
title_sort c2238 anp gene variant promotes increased platelet aggregation through the activation of nox2 and the reduction of camp
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/5096f14f92b54f8a9f71e3827294a48d
work_keys_str_mv AT robertocarnevale c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT pasqualepignatelli c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT giacomofrati c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT cristinanocella c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT rositastanzione c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT danielepastori c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT simonamarchitti c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT valentinavalenti c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT mariasantulli c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT emanuelebarbato c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT teresastrisciuglio c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT leonardoschirone c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT carminevecchione c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT francescovioli c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT massimovolpe c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT speranzarubattu c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
AT sebastianosciarretta c2238anpgenevariantpromotesincreasedplateletaggregationthroughtheactivationofnox2andthereductionofcamp
_version_ 1718394277477744640